OCREVUS (ocrelizumab) is now approved by the FDA for treating patients with relapsing and primary progressive forms of multiple sclerosis (MS).

McKesson Specialty Health is excited about the treatment opportunity MS patients now have with the FDA approval of OCREVUS. Place your order online via Customer Center or by calling Customer Care at 855.477.9800. If you are not a customer and want to order OCREVUS, please call Customer Care to set up an account.

DESCRIPTION

MAT

CAT

NDC

MFR

OCREVUS 30MG/ML 10ML SDV  1/EA

5006820

003-147

50242-0150-01

GENENTECH

OCREVUS Resources for Healthcare Providers

OCREVUS Information for Patients

OCREVUS Product Information
OCREVUS Overview
OCREVUS Full Prescribing Information

OCREVUS Reimbursement-Coding
OCREVUS Prior Authorization Support
OCREVUS Tips for Billing & Coding Drugs Not Yet Assigned a J Code

About Our Solutions for Neurology

We are the leading distributor of specialty pharmaceuticals and supplies to providers treating patients with neurological disorders.  We work closely with customers to provide:

  • Reliable and Trusted Service 
    Drug distribution is in our DNA. Today many of the largest neurology practices rely on us for high-quality distribution, competitive prices and customer service.
     
  • Practice Management Solutions that Capture Revenue and Operational Efficiencies
    Beyond drug distribution, we offer practice management solutions that help capture all revenue your practice is entitled to, lower drug costs, and increase operational efficiency through time savings and lean inventory.
     
  • Dedicated Specialist Support for Your Practice
    We get neurology. We are the only specialty distributor with a neurology service team who visits you in person. Your dedicated neurology account specialist will help you identify cost savings, troubleshoot problems and access the right solutions to reach your performance goals.

Learn more about our solutions for Neurology practices.